Evaluation of Tears Naturale® Free and Tears Naturale® II Lubricant Eye Drops

The purpose of this post-market clinical follow-up (PMCF) study is to describe the effectiveness and safety of Tears Naturale® Free and Tears Naturale® II lubricant eye drops in subjects experiencing dry eye (DE) symptoms.

Each subject's participation will last approximately 30 days and include three scheduled visits: a screening/baseline clinic visit on Day 1 (Visit 1), a telephone follow-up visit on Day 15 (-2/+5 days) (Visit 2), and an in-office visit on Day 30 (-2/+5 days) (Visit 3). This study will be conducted in Canada.

Key Inclusion Criteria: * Able to read, understand, and sign an Institutional Review Board (IRB)/Independent Ethics Committee (IEC) approved informed consent form in English or French. * Able to attend all study visits as required as per protocol. * Mild to moderate dry eye disease. * Willing to discontinue use of all habitual artificial tear supplements and use only the study device for the entire study duration. * Other protocol-defined inclusion criteria may apply. Key Exclusion Criteria: * Any known allergic reactions to the study products or its ingredients. * Ocular injury to either eye in the past 3 months prior to screening. * Ocular surgery within the previous 6 months or ocular surgery planned during the study. * Use of any systemic medication known to cause dry eye for less than 1 month before the Screening/Baseline visit. * Other protocol-defined exclusion criteria may apply.